Concepedia

Jonathan D. Kursar

JD

11

Publications

893

Citations

11

H-Index

1989

Active since

Affiliations

Eli Lilly (United States)(Current)

Cardinal Glennon Children’s Medical Center

Jonathan D. Kursar is an author at Eli Lilly (United States) specializing in medicine, developmental biology, and pharmacology.

Top concepts

Publications per year

1989–2016

11

Publications

11

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.

Jonathan D. Kursar, David L. Nelson, David B. Wainscott et al. · Molecular Pharmacology · 1992 · 183 citations

Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.

Jonathan D. Kursar, David L. Nelson, David B. Wainscott et al. · Molecular Pharmacology · 1994 · 163 citations · Full text

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.

David B. Wainscott, Marlene L. Cohen, Kathryn W. Schenck et al. · Molecular Pharmacology · 1993 · 116 citations

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.

David B. Wainscott, Virginia L. Lucaites, Jonathan D. Kursar et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 115 citations · Full text

A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer

Shubham Pant, Suzanne F. Jones, Carla Kurkjian et al. · European Journal of Cancer · 2016 · 89 citations

Rows per page

1–5 of 11